Morning Briefing
Summaries of health policy coverage from major news organizations
Cancer Drug Joins List Of Medicines In Short Supply
The drug Doxil, which is the second-line treatment for patients with ovarian cancer, multiple myeloma or Kaposi's sarcoma, has been in short supply since mid-summer.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
